Scarica l'app Stockscreener
3.40
3.41%
-0.12
Design Therapeutics Inc Azioni (DSGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
4.77%
14.40
|
15.12 | 18.82 | 22.60 | 21.65 |
| Operating Income/Loss |
4.77%
-14.40
|
-15.12 | -18.82 | -22.60 | -21.65 |
| Income/Loss From Continuing Operations Before Tax |
6.22%
-11.11
|
-11.84 | -15.79 | -19.94 | -19.29 |
| Income/Loss From Continuing Operations After Tax |
6.22%
-11.11
|
-11.84 | -15.79 | -19.94 | -19.29 |
|
Net Income/Loss
|
6.22%
-11.11
|
-11.84 | -15.79 | -19.94 | -19.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
157.68K%
56.49
|
0.0358 | 55.99 | 55.95 | 55.91 |
| Diluted Average Shares |
157.68K%
56.49
|
0.0358 | 55.99 | 55.95 | 55.91 |
| Basic Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.28 | -0.36 | -0.35 |
| Diluted Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.28 | -0.36 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):